High levels of human anti-human antibodies to adalimumab in a patient not responding to adalimumab treatment

被引:32
作者
Bartelds, G. M.
Wolbink, G. J.
Stapel, S.
Aarden, L.
Lems, W. F.
Dijkmans, B. A. C.
T Nurmohamed, M. [1 ]
机构
[1] Jan Van Breemen Inst, Dept Rheumatol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[3] Sanquin Res, Amsterdam, Netherlands
关键词
D O I
10.1136/ard.2005.049858
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1249 / 1250
页数:4
相关论文
共 6 条
[1]   Drug therapy - New drugs for rheumatoid arthritis [J].
Olsen, NJ ;
Stein, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2167-2179
[2]   Rituximab treatment in patients with primary Sjogren's syndrome [J].
Pijpe, J ;
van Imhoff, GW ;
Spijkervet, FKL ;
Roodenburg, JLN ;
Wolbink, GJ ;
Mansour, K ;
Vissink, A ;
Kallenberg, CGM ;
Bootsma, H .
ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :2740-2750
[3]  
van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO
[4]  
2-K
[5]   Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis [J].
Wolbink, GJ ;
Voskuyl, AE ;
Lems, WF ;
de Groot, E ;
Nurmohamed, MT ;
Tak, PP ;
Dijkmans, BAC ;
Aarden, L .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (05) :704-707
[6]   Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis [J].
Wolbink, GJ ;
Vis, M ;
Lems, W ;
Voskuyl, AE ;
de Groot, E ;
Nurmohamed, MT ;
Stapel, S ;
Tak, PP ;
Aarden, L ;
Dijkmans, B .
ARTHRITIS AND RHEUMATISM, 2006, 54 (03) :711-715